Course summary
This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process. It addresses key aspects of preclinical drug evaluation through the study of:
- Drug discovery and development
- Safety pharmacology
- Mechanisms of drug-induced toxicities
- Regulatory affairs
- Bioanalytical sciences
Modules
All years: preclinical models for drug evaluation; research and analytical methods in safety pharmacology; toxicology and safety pharmacology; experimental design for safety pharmacology; molecular mechanisms of toxicity; research project.
Assessment method
Research project.
Entry requirements
A 2.2 Honours degree or above in a related scientific discipline e.g. biosciences, chemistry, biomedical, medical, pharmaceutical, pharmacological, or toxicological studies; applications are also welcome from candidates with non standard qualification, with significant relevant experience. IELTS at 6.0 or the equivalent.
Fees and funding
Tuition fees
No fee information has been provided for this course
Tuition fee status depends on a number of criteria and varies according to where in the UK you will study. For further guidance on the criteria for home or overseas tuition fees, please refer to the UKCISA website .
Additional fee information
Provider information
University of Bradford
Richmond Road
Bradford
BD7 1DP